Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus

Rheumatology

Volumn 46, Issue 3, 2007, Pages 467-472

  Appenzeller, S ^a   Amorim, B J ^a   Ramos, C D ^a   Rio, P A ^a   de C Etchebehere, E C S ^a   Camargo, E E ^a   Cendes, F ^a   Costallat, L T L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

SLE; SPECT; VBM

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYSTEINE ETHYL ESTER TC 99M; IMMUNOSUPPRESSIVE AGENT;

ACUTE CONFUSION; ADULT; ANXIETY DISORDER; ARTICLE; ASEPTIC MENINGITIS; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; MALE; MOOD DISORDER; MORPHOMETRICS; MOTOR DYSFUNCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; SCREENING TEST; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD DISEASE; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL LOBE; VOLUNTEER;

ADOLESCENT; ADULT; BRAIN; BRAIN MAPPING; CYSTEINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33847359593     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel255     Document Type: Article

References (61)

1. West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994;20:129-58.
2. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Int Med 1996;156:1337-44.
3. Sibbitt WL, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999;42:2026-38.
4. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am J Med 1995;99:153-63.
5. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988;31:159-66.
6. Jarek MJ, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994;37:1609-13.
7. Sanna G, Piga M, Terryherry JW et al. Central nervous system involvement in systemic lupus erythematosus: Cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000;9:573-83.
8. Huang WS, Chiu PY, Tsai CH, Hao A, Lee CC. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99mECD brain SPECT. Rheumatol Int 2002;22:178-81.
9. Sundgren PC, Jennings J, Attwood JT et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005;47:576-85.
10. Oku K, Atsumi T, Furukawa S et al. Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement. Rheumatology 2003;12:773-7.
11. Liu FY, Huang WS, Kao CH, Yean RF, Wang JI, Hu ST. Usefulness of Tc-99 ECD brain SPECT to evaluate the effects of methylpredinisolone pulse therapy in lupus erythematosus with brain involvement: A preliminary report. Rheumatol Int 2003;23:182-5.
12. Handa R, Sahota P, Kumar M et al. In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). Magn Reson Imaging 2003;21:1033-7.
13. Colamussi P, Trotta F, Ricci R et al. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations. Nuclear Medicine Communications 1997;18:269-73.
14. Zhang X, Zhu Z, Zhang F, Shu H, Li F, Dong Y. Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: A case-control study. Arthritis Rheum 2005;53:845-9.
15. Lin WY,Wang SJ, Yen TC, Lan JL. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 1997;38:1112-5.
16. Kao CH, Lan JL, ChangLai SP, Liao KK, Yen RF, Chieng PU. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999;26:129-34.
17. Huang WS, Chiu PY, Tsai CH, Kao A, Lee CC. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol Int 2002;22:178-81.
18. Chen JJ, Yen RF, Kao A, Lin CC, Lee CC. Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings. Clin Rheumatol 2002;21:516-9.
19. Waterloo K, Omdal R, Sjoholm H et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001;248:595-602.
20. Lopez-Longo FJ, Carol N, Almoguera MI et al. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage. Lupus 2003;21:813-9.
21. Zugbal IG, Spencer SS, Iman K et al. Differences images calculated from ictal and interictal technesium-00m-HMPAO SPECT scans of epilepsy. J Nucl Med 1995;36:684-9.
22. Spanaki MV, Spencer SS, Wiesnieski G et al. Evolution and localization of postictal blood flow changes in partial seizures demonstrated by SPECT: Use of quantitative differences images. J Epilepsy 1998;11:25-33.
23. O'Brien TJ, So EL, Mullan BP et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing surgical seizure focus. Neurology 1998;50:445-54.
24. Stefan H, Bauer J, Feistel H et al. Regional cerebral blood flow during focal seizures of temporal and frontocentral onset. Ann Neurol 1990;27:162-6.
25. Rowe CC, Berkovic SF, Austin MC et al. Patterns of postictal cerebral blood flow in temporal lobe epilepsy. Neurology 1991;41:1096-103.
26. Duncan R, Patterson J, Roberts R et al. Ictal/postictal SPECT in the pre-surgical localization of complex partial seizures. J Neurol Neurosurg Psychiatry 1993;56:141-8.
27. Friston KJ, Holmes A, Poline JB et al. Detecting activations in PET and fMRI: Levels of inference and power. Neuroimage 1996;40:223-35.
28. Friston KJ, Holmes AP, Worsley KJ et al. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 1995;2:89-210.
29. West J, Fitzpatrick JM, Wang MY et al. Comparison and evaluation of retrospective intermodality image registration techniques. J Comput Assist Tomogr 1997;21:554-66.
30. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
31. Liang MH, Corzillius M, Bae SC et al. The American College Nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 1999;42:599-608.
32. The Committee on prognosis studies in SLE, Bombardier C, Gladman DD, Urowitz M, Caron D, Chang C. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
33. Gladman D, Glinzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-78.
34. Folstein MF, Folstein SE, Folstein PR. "Mini mental state" A practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res 1975;12:189-98.
35. Spranoel HZ. The psychoeducational use and interpretation of the Wechsler Adult Intelligence Scale-Revised. Springfield: CC Thomas, 1992.
36. Wechsler in Muistiasteikko, Suom. Anja Manner. Helsinki: Psykologien Kustannus, 1986.
37. Delis DC, Kramer JH, Kaplan E et al. California verbal learning test research edition manual. San Antonio: The Psychological Corporation, 1987.
38. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1995.
39. Heaton RK, Chelune GJ, Talley JL et al. Wisconsin Card Sorting Test Manual, revised and expanded. Odessa: Psychological Assessment Resources Inc., 1993.
40. Beck AT, Beamesderfer A. Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiat 1974;7:151-69.
41. Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep 1974;34:1184-6.
42. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
43. Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 1984;39:187-93.
44. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anticardiolipine antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
45. Brandt JT, Triplett DA, Scharer I. Criteria for the diagnosis of lupus anticoagulant: An update. Thromb Haemost 1995;74:1185-90.
46. Ashburner J, Friston KJ. Multimodal image coregistration and partitioning - a unified framework. Neuroimage 1997;6:209-17.
47. Ashburner J, Neelin P, Collins DL, Evans AC, Friston K. Incorporating prior knowledge into imaging registration. NeuroImage 2001;6:344-52.
48. Friston KJ, Holmes AP, Worsley KP, Proline JB, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 1995;2:189-210.
49. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870-8.
50. Rubbert A, Marienhagen J, Pirner K et al. Single-photon emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:1253-62.
51. Emmi L, Bramati M, De Cristofaro MT et al. MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 1993;11:13-20.
52. Nossent JC, Hovestadt A, Schonfeld DH, Swaak AJ. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991;34:1397-403.
53. Szer IS, Miller JH, Rawlings D, Shaham B, Bernstein B. Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography. J Rheumatol 1993;20:2143-8.
54. Kovacs JA, Urowitz MB, Gladman DD, Zeman R. The use of single photon emission computerized tomography in neuropsychiatric SLE: A pilot study. J Rheumatol 1995;22:1247-53.
55. Reiff A, Miller J, Shaham B, Bernstein B, Szer IS. Childhood central nervous system lupus: Longitudinal assessment using single photon emission computed tomography. J Rheumatol 1997;24:2461-5.
56. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. Am J Roentgenol 1985;144:1027-31.
57. Stoppe G, Wildhagen K, Seidel JW et al. Position emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990;40:304-8.
58. Chia-Hung K, Yung-Jen HL, Jung-Liang C, Sheng-K Ping L, Ko-Kaung L, Poon-Ung C. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999;42:61-8.
59. Colamussi P, Giganti M, Cittanti C et al. Brain single photon emission tomography with 99m Tc-HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995;22:17-24.
60. Oda K, Matsushima E, Okubo Y et al. Abnormal regional cerebral blood flow in systemic lupus erythematosus patients with psychiatric symptoms. J Clin Psychiatry 2005;66:907-13.
61. Abreu MR, Jakosky A, Folgerini M, Brenol JC, Xavier RM, Kapczinsky F. Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT. Clin Imaging 2005;29:215-21.